Breast Cancer Research and Treatment

Top Research Topics at Breast Cancer Research and Treatment?

Breast Cancer Research and Treatment covers a variety of subjects, including Breast cancer, Internal medicine, Oncology, Cancer and Cancer research. Breast cancer research presented is mostly focused on the subject of Breast disease. It addresses concerns in the field of Internal medicine by exploring it in line with topics in Endocrinology which intersect with Receptor subjects.

The work on Oncology tackled in Breast Cancer Research and Treatment brings together disciplines like Odds ratio, Proportional hazards model, Genotype, Hazard ratio and Cohort. It centers on topics in Cancer, with a focus on Metastasis. Breast Cancer Research and Treatment focuses on Cancer research but the discussions also offer insight into other areas such as Cancer cell, Cell culture, Cell growth and Carcinogenesis.

Immunohistochemistry and Carcinoma are some of the facets of Pathology tackled in Breast Cancer Research and Treatment. The research on Surgery discussed in Breast Cancer Research and Treatment draws on the closely related field of Mastectomy. The Gynecology study featured in the journal draws connections with the study of Risk factor.

• Breast cancer (85.19%)
• Internal medicine (57.55%)
• Oncology (38.22%)

What are the most cited papers published in the journal?

• An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients. (1823 citations)
• The Nottingham Prognostic Index in primary breast cancer. (874 citations)
• Epidemiology of basal-like breast cancer (718 citations)

Research areas of the most cited articles at Breast Cancer Research and Treatment:

The most cited articles explore disciplines such as Breast cancer, Internal medicine, Cancer, Oncology and Cancer research. The studies on Breast cancer discussed at the most cited articles can also contribute to research in the domains of Gynecology, Surgery and Pathology. While Internal medicine is the key highlight in the published articles, thet also covered some subjects on Endocrinology and Receptor.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cancer
• Gene

The previous edition focused in particular on these issues:

Breast Cancer Research and Treatment focuses on Breast cancer, Internal medicine, Oncology, Cancer and Chemotherapy. Specifically, studies on Metastatic breast cancer are prevalent in the Breast cancer works discussed. The research on Oncology featured in the journal combines topics in other fields like Immunohistochemistry, Clinical endpoint, Estrogen receptor and Disease.

Breast Cancer Research and Treatment primarily discusses Cancer topics, particularly Metastasis and Mastectomy. While Breast Cancer Research and Treatment focused on Chemotherapy, it was also able to explore topics like Neoadjuvant therapy and Radiology. The concepts on Cancer research presented in Breast Cancer Research and Treatment can also apply to other research fields, including Cell growth and Gene knockdown.

The most cited articles from the last journal are:

• Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach. (8 citations)
• Immune microenvironment in different molecular subtypes of ductal breast carcinoma (8 citations)
• KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Breast Cancer Research and Treatment (based on the number of publications) are:

• Ian O. Ellis (103 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• Steven A. Narod (101 papers) published 2 papers at the last edition, 1 more than at the previous edition,
• Andrew R. Green (84 papers) published 7 papers at the last edition, 1 less than at the previous edition,
• Emad A. Rakha (81 papers) published 7 papers at the last edition, 1 less than at the previous edition,
• Gabriel N. Hortobagyi (68 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Breast Cancer Research and Treatment (based on the number of publications) are:

• Harvard University (463 papers) published 37 papers at the last edition, 15 more than at the previous edition,
• University of Texas MD Anderson Cancer Center (286 papers) published 16 papers at the last edition, 4 more than at the previous edition,
• University of Toronto (262 papers) published 13 papers at the last edition, 5 more than at the previous edition,
• Memorial Sloan Kettering Cancer Center (211 papers) published 17 papers at the last edition, 10 more than at the previous edition,
• University of North Carolina at Chapel Hill (196 papers) published 12 papers at the last edition, 4 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 2.86% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 24.63% were posted by at least one author from the top 10 institutions publishing in the journal. Another 10.11% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.58% of all publications and 49.68% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Opportunities in the Field of Breast Cancer Research

To contribute to the progression of the research work in breast cancer treatment, having a solid educational foundation is crucial. Several reputable institutions offer specialized programs and degrees focused on deepening the understanding of this complex type of cancer. In particular, the nursing profession plays a pivotal role in taking care of breast cancer patients hence, pursuing a degree in nursing can be a fulfilling path for those who want to make a notable difference.

Among the broad range of program options across diverse institutions, taking an online course allows flexibility and convenience. For individuals who want to balance their current jobs or family obligations while gaining specialized knowledge in the field, an online program can be the best option. You can check out the best online nursing programs in Wisconsin. They offer programs that train individuals in providing quality and compassionate care for patients with differing health issues including breast cancer. This higher learning experience not only equips individuals with essential theoretical knowledge, but also provides practical strategies that can be applied in real-life healthcare settings.

Remember that the success in the field of breast cancer research and treatment literally means life for someone. Making the decision to pursue further studies can be a significant step towards gaining proficiency in this essential sector.